Virtu Financial LLC Takes Position in OS Therapies Inc (NYSE:OSTX)

Virtu Financial LLC purchased a new position in OS Therapies Inc (NYSE:OSTX) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 10,045 shares of the company’s stock, valued at approximately $28,000.

OS Therapies Trading Up 1.5 %

Shares of OSTX opened at $3.97 on Friday. The company’s 50 day moving average is $2.69. OS Therapies Inc has a 52 week low of $1.58 and a 52 week high of $6.48.

Analyst Ratings Changes

Several brokerages have issued reports on OSTX. EF Hutton Acquisition Co. I raised shares of OS Therapies to a “strong-buy” rating in a research note on Tuesday, September 3rd. Maxim Group started coverage on OS Therapies in a research note on Tuesday, November 26th. They issued a “buy” rating and a $8.00 price objective for the company.

OS Therapies Company Profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers.